Inventor
ELTEPU LAXMAN
US21 patents
⚠️ This page may combine multiple inventors who share the name “ELTEPU LAXMAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARBUTUS BIOPHARMA CORP
10 patentsUS9682139B2Jun 20, 2017
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP46 citations98
US10117941B2Nov 6, 2018
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP12 citations92
US9764036B2Sep 19, 2017
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP19 citations92
US11077197B2Aug 3, 2021
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP3 citations84
US10821186B2Nov 3, 2020
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP4 citations84
US9707292B2Jul 18, 2017
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP5 citations84
US12042541B2Jul 23, 2024
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP0 citations73
US12453776B2Oct 28, 2025
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP0 citations62
US11712476B2Aug 1, 2023
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP0 citations59
US10835612B2Nov 17, 2020
Lipids and compositions for the delivery of therapeutics
ARBUTUS BIOPHARMA CORP0 citations52
ALIGOS THERAPEUTICS INC
3 patentsUS11549110B2Jan 10, 2023
Modified short interfering nucleic acid (siNA) molecules and uses thereof
ALIGOS THERAPEUTICS INC5 citations72
US12454691B2Oct 28, 2025
Modified short interfering nucleic acid (siNA) molecules and uses thereof
ALIGOS THERAPEUTICS INC0 citations60
US12129469B2Oct 29, 2024
Modified short interfering nucleic acid (siNA) molecules and uses thereof
ALIGOS THERAPEUTICS INC1 citations59
SIRIUS THERAPEUTICS INC
3 patentsUS11597744B2Mar 7, 2023
Chiral phosphoramidite auxiliaries and methods of their use
SIRIUS THERAPEUTICS INC2 citations69
US11981703B2May 14, 2024
Polynucleotide constructs
SIRIUS THERAPEUTICS INC2 citations68
US12269839B2Apr 8, 2025
Chiral phosphoramidite auxiliaries and methods of their use
SIRIUS THERAPEUTICS INC0 citations59